A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2014; you can also visit the original URL.
The file type is application/pdf
.
Epigenetics, DNA Methylation, and Chromatin Modifying Drugs
2009
Annual Review of Pharmacology and Toxicology
Evidence is emerging that several diseases and behavioral pathologies result from defects in gene function. The best-studied example is cancer, but other diseases such as autoimmune disease, asthma, type 2 diabetes, metabolic disorders, and autism display aberrant gene expression. Gene function may be altered by either a change in the sequence of the DNA or a change in epigenetic programming of a gene in the absence of a sequence change. With epigenetic drugs, it is possible to reverse aberrant
doi:10.1146/annurev-pharmtox-061008-103102
pmid:18851683
fatcat:stepfhks2zdehdlaj63vsi27wm